|
2024 Other Outputs MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR)Yeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1749.1 - Insertion of durable ventricular assist device (VAD) for use as destination therapy: Applicant Developed Assessment Report (ADAR). Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Other Outputs MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO ConfirmationYeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1783 - Genetic testing to detect PIK3CA mutations in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised inavolisib: PICO Confirmation. Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Other Outputs MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of AustraliaHettiarachchi, Ruvini and Tuffaha, Haitham (2024). MSAC Application No. 1593.1 - Bioinductive implant for the repair of rotator cuff tear: Applicant Developed Assessment Report (ADAR): Commonwealth of Australia. Canberra, ACT Australia: Commonwealth of Australia. |
|
2024 Other Outputs MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO ConfirmationYeoh, S., Hettiarachchi, R. and Tuffaha, H. (2024). MSAC Application No. 1766 – Genetic testing to detect AKT-pathway alterations in patients with hormone receptor-positive, HER2-negative advanced breast cancer, to determine eligibility for PBS subsidised capivasertib treatment: PICO Confirmation. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2023 Other Outputs Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessmentMaguire, Angela M., Soole, Rebecca, Beilby, Hannah, Tabinga, Angeli, Barker, Natalie, Fear, Nicola T., Kenardy, Justin, Tuffaha, Haitham and Khoo, Andrew (2023). Emerging and adjunct treatments for common mental health conditions affecting veterans: a rapid evidence assessment. Canberra, ACT Australia: Commonwealth of Australia. |
|
2023 Other Outputs (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2023 Other Outputs (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2023 Other Outputs (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, PICO Confirmation. Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2023 Other Outputs (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.Hettiarachchi, R. and Tuffaha, H. (2023). (August 2023), MSAC Application No. 1749 - Insertion of durable ventricular assist device (VAD) for use as destination therapy, Applicant Developed Assessment Report (ADAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2023 Other Outputs (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACTHettiarachchi, R. and Tuffaha, H. (2023). (April 2023), MSAC Application No. 1734 - Intravascular lithotripsy (IVL) for the treatment of moderately or severely calcified peripheral artery disease, PICO Confirmation. Commonwealth of Australia, Canberra, ACT. Canberra, ACT, Australia: Commonwealth of Australia. |
|
2022 Other Outputs Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic strokeEdmunds, Kim and Tuffaha, Haitham (2022). Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke. Brisbane, QLD Australia: The University of Queensland. |
|
2022 Other Outputs Assessing the impact of clinical trials: a scoping literature reviewTuffaha, Haitham, Birch, Stephen and Oakley, Padraig (2022). Assessing the impact of clinical trials: a scoping literature review. Melbourne, VIC Australia: Australian Clinical Trials Alliance. |
|
2022 Other Outputs A pilot study to prospectively estimate the health and economic return on research investmentTuffaha, Haitham and Birch, Stephen (2022). A pilot study to prospectively estimate the health and economic return on research investment. Melbourne, VIC Australia: Australian Clinical Trials Alliance. |
|
2021 Other Outputs Estimating the return on investment of a randomised controlled trial on telehealth-based medical nutrition intervention in rural and regional AustraliaTuffaha, Haitham and Birch, Stephen (2021). Estimating the return on investment of a randomised controlled trial on telehealth-based medical nutrition intervention in rural and regional Australia. Armidale, NSW, Australia: Spinifex Network. |
|
2020 Other Outputs ACTA Research Prioritisation FrameworkTuffaha, Haitham, Morton, Rachael and Cumpston, Miranda (2020). ACTA Research Prioritisation Framework. Melbourne, VIC, Australia: Australian Clinical Trials Alliance. |
|
2018 Other Outputs Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain ProgramVecchio, Nerina, Tuffaha, Haitham, Radford, Katrina and Chai, Andreas (2018). Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain Program. Gold Coast, QLD, Australia: Griffith University. |
|
2016 Other Outputs Economic modelling of healthcare services for prostate cancerGordon, Louisa, Tuffaha, Haitham, James, Robbie and Scuffham, Paul (2016). Economic modelling of healthcare services for prostate cancer. Monographs in Prostate Cancer St Leonards, NSW, Australia: Prostate Cancer Foundation of Australia. |
|
2016 Other Outputs Value of Information Analysis Applications in Healthcare InterventionsTuffaha, Haitham (2016). Value of Information Analysis Applications in Healthcare Interventions. PhD Thesis, School of Medicine , Griffith University. doi: 10.25904/1912/3508 |
|
2015 Other Outputs Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment ReportTuffaha, Haitham, Gordon, Louisa and Scuffham, Paul (2015). Transient elastography at 50Hz for the diagnosis of liver fibrosis in patients with hepatitis B or C: MSAC Assessment Report. Canberra, ACT Australia: Department of Health. |
|
2014 Other Outputs Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatmentGordon,Louisa, Sowa,M, Tuffaha, Haitham and Scuffham, Paul (2014). Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment. Canberra, ACT, Australia: Commonwealth of Australia. |
